FDA Webview
X

Free FDA Notices

Panel on Pediatric Cancer Drug Development

02/27/2008

Federal Register Notice: FDA’s Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee will meet 4/16, from 8:30 a.m. to 3:30 p.m. at CDER’s Advisory Committee Conference Room, Rm. 1066, 5630 Fishers Lane, Rockville, MD. The subcommittee will consider and discuss opportunities for enhancing global pediatric oncology drug development and expanding international regulatory interactions given the 1/07 legislation introduced in the European Union that governs the development and authorization of medicines for use in children aged 0 to 17 years. Contact Nicole Vesely, (301) 827-6793. To view this notice, click here.

LATEST NEWS